Side-by-side comparison of AI visibility scores, market position, and capabilities
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
SF YC W24 AI compliance automation for SOC 2/HIPAA/ISO/GDPR at $35.8M total ($32M Insight Partners Series A 2025 at $300M val); 500+ companies, profitable, doubling quarterly competing with Vanta and Drata for AI-native evidence collection.
Delve is a San Francisco-based AI-native compliance automation platform — backed by Y Combinator (W24) with $35.8 million in total funding including a $3.3 million seed in 2024 from General Catalyst, FundersClub, Soma Capital, and YC, followed by a $32 million Series A in 2025 led by Insight Partners at a $300 million valuation — providing 500+ high-growth companies and Fortune 500 enterprises with AI agents that automatically collect security compliance evidence, map controls to frameworks, and maintain continuous compliance for SOC 2, HIPAA, ISO 27001, GDPR, PCI DSS, and custom regulatory frameworks. Profitable and doubling revenue quarterly, Delve's AI agents continuously gather compliance evidence from connected systems without the API-only approach that limits traditional compliance tools.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.